Mirada Medical Limited

Mirada Medical is a UK-based medical imaging software company founded in 2000, with deep roots in Oxford University research (originating from 1998). Headquartered in Oxford, the company specializes in AI-driven, vendor-neutral software solutions designed to accelerate cancer care through precision imaging. The company's portfolio targets three primary clinical domains: radiation oncology, diagnostic imaging, and interventional radiology. Key products include Mirada RTx, which automates radiation therapy planning workflows and enhances treatment planning confidence, and Mirada XD, an advanced image registration and visualization platform for enterprise diagnostic imaging. Mirada's solutions incorporate deep learning and AI-based quantification tools to support clinician productivity, multi-timepoint follow-up analysis, and automated reporting (particularly for PET/CT and PET/MR imaging). The company maintains strong partnerships with major medical device manufacturers including Canon and Boston Scientific, and collaborates with clinical facilities on research-driven innovation to improve patient outcomes and address imaging-related clinical challenges.